Anthony J. Schaeffer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Anthony J. Schaeffer has a total of 78 co-authors. Here are the top co-authors by number of shared publications:
- Kiarad Fendereski
Division of Urology, Department of Surgery, University of Utah School of Medicine, Salt Lake City, UT
4 shared publications - Antoine E. Khoury
Division of Pediatric Urology, Children's Hospital of Orange County, Orange CA, USA; Department of Urology, University of California-Irvine School of Medicine, Orange CA, USA
2 shared publications - Amanda F. Saltzman
University of Kentucky, Department of Urology, Lexington, KY
1 shared publication - Ariah D. Jansen-Booker
Division of Urology, University of Utah, Primary Children's Hospital, Suite 3550, Salt Lake City, Utah 84113
1 shared publication - Brian P. Wiseman
Division of Urology, University of Utah, Primary Children's Hospital, Suite 3550, Salt Lake City, Utah 84113
1 shared publication - Briony K. Varda
Division of Urology, Children's National Hospital, Washington, DC, USA
1 shared publication
Latest Publications
- Open Access
- 16 May 2026
- Published by Elsevier in Journal of Pediatric Urology
- p. 106024
Establishing a clinician-prioritized pediatric urology clinical research agenda in the United States
- 16 May 2026
- Published by Elsevier in Journal of Pediatric Urology
- p. 106024
Open AccessEstablishing a clinician-prioritized pediatric urology clinical research agenda in the United States
- Open Access
Epigenetic Regulation of Immune Dysfunction in Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)
Background: Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a prevalent and debilitating condition with unclear etiology. Increasing evidence implicates immune dysregulation, yet the molecular mechanisms underlying impaired immune regulation remain poorly defined. This study investigated the role of adaptive immune responses and DNA methylation in CP/CPPS pathogenesis. Methods: Voided bladder 3 (VB3) urine samples from CP/CPPS patients and healthy controls were analyzed for CD4 T cell markers and lineage-defining transcription factors. DNA methylation profiling of peripheral blood mononuclear cells (PBMCs) and purified CD4 T cells was performed using targeted methylation arrays. Functional assays evaluated IL-10 production following lipopolysaccharide (LPS) stimulation, with or without azacitidine (AZA), a DNA methyltransferase inhibitor that reverses methylation-dependent gene silencing. In vivo relevance was assessed using the experimental autoimmune prostatitis (EAP) mouse model. Results: VB3 samples from CP/CPPS patients demonstrated elevated CD4 T cell transcripts with a Th17/Th1 (RORgammaT/TBET) bias and reduced FOXP3 expression. DNA methylation analysis revealed hypermethylation of IL10 and FOXP3 promoters and hypomethylation of inflammatory genes including CD274, ITGAL, and TNF. PBMCs from patients exhibited diminished IL-10 secretion in response to LPS, which was restored by azacitidine treatment. In the EAP model, recombinant IL-10 administration failed to attenuate pelvic allodynia, whereas azacitidine significantly reduced pain sensitivity. Conclusions: CP/CPPS is associated with widespread epigenetic reprogramming of immune regulatory genes leading to impaired IL10 mediated immune regulation. Pharmacologic inhibition of DNA methylation restored IL10 responses and alleviated pain in vivo, supporting demethylation therapy as a potential strategy for treating chronic prostatic inflammation and pelvic pain.
Open AccessEpigenetic Regulation of Immune Dysfunction in Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)
Background: Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a prevalent and debilitating condition with unclear etiology. Increasing evidence implicates immune dysregulation, yet the molecular mechanisms underlying impaired immune regulation remain poorly defined. This study investigated the role of adaptive immune responses and DNA methylation in CP/CPPS pathogenesis. Methods: Voided bladder 3 (VB3) urine samples from CP/CPPS patients and healthy controls were analyzed for CD4 T cell markers and lineage-defining transcription factors. DNA methylation profiling of peripheral blood mononuclear cells (PBMCs) and purified CD4 T cells was performed using targeted methylation arrays. Functional assays evaluated IL-10 production following lipopolysaccharide (LPS) stimulation, with or without azacitidine (AZA), a DNA methyltransferase inhibitor that reverses methylation-dependent gene silencing. In vivo relevance was assessed using the experimental autoimmune prostatitis (EAP) mouse model. Results: VB3 samples from CP/CPPS patients demonstrated elevated CD4 T cell transcripts with a Th17/Th1 (RORgammaT/TBET) bias and reduced FOXP3 expression. DNA methylation analysis revealed hypermethylation of IL10 and FOXP3 promoters and hypomethylation of inflammatory genes including CD274, ITGAL, and TNF. PBMCs from patients exhibited diminished IL-10 secretion in response to LPS, which was restored by azacitidine treatment. In the EAP model, recombinant IL-10 administration failed to attenuate pelvic allodynia, whereas azacitidine significantly reduced pain sensitivity. Conclusions: CP/CPPS is associated with widespread epigenetic reprogramming of immune regulatory genes leading to impaired IL10 mediated immune regulation. Pharmacologic inhibition of DNA methylation restored IL10 responses and alleviated pain in vivo, supporting demethylation therapy as a potential strategy for treating chronic prostatic inflammation and pelvic pain.
- 17 October 2025
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 22 (1) , 105634
Discharge one hour sooner: Comparing post-operative metrics between spinal and general anesthetics among male infants undergoing circumcision
- 17 October 2025
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 22 (1) , 105634
Discharge one hour sooner: Comparing post-operative metrics between spinal and general anesthetics among male infants undergoing circumcision
- 1 June 2024
- Published by Medpharm Publications in African Urology
- Vol. 4 (se1) , S20-S25
Bladder exstrophy-epispadias-cloacal exstrophy complex: characteristics, aetiologies, and epidemiologic findings
Bladder exstrophy-epispadias-cloacal exstrophy complex (BEEC) is a spectrum of congenital urologic anomalies that involve the bladder, urethra, genitalia, and pelvic musculoskeletal system, and can affect urinary continence, sexual health, and fertility. BEEC includes a wide spectrum of anatomical abnormalities with different levels of severity: epispadias represents the mildest phenotype, classic bladder exstrophy (CBE) is the most common defect, and cloacal exstrophy (CE) – often referred to as omphalocele, exstrophy, imperforate anus, and spinal defects (OEIS) complex – is the most severe form. BEEC disorders cause significant health problems and affect the health-related quality of life (QoL) of affected individuals. There have been significant insights into the aetiology of BEEC in the last decade. Specifically, recent genetic studies have suggested that downstream regulator(s) of p63, Isl1, and other genes may play a role in the failure of the lower urinary tract to close.
- 1 June 2024
- Published by Medpharm Publications in African Urology
- Vol. 4 (se1) , S20-S25
Bladder exstrophy-epispadias-cloacal exstrophy complex: characteristics, aetiologies, and epidemiologic findings
Bladder exstrophy-epispadias-cloacal exstrophy complex (BEEC) is a spectrum of congenital urologic anomalies that involve the bladder, urethra, genitalia, and pelvic musculoskeletal system, and can affect urinary continence, sexual health, and fertility. BEEC includes a wide spectrum of anatomical abnormalities with different levels of severity: epispadias represents the mildest phenotype, classic bladder exstrophy (CBE) is the most common defect, and cloacal exstrophy (CE) – often referred to as omphalocele, exstrophy, imperforate anus, and spinal defects (OEIS) complex – is the most severe form. BEEC disorders cause significant health problems and affect the health-related quality of life (QoL) of affected individuals. There have been significant insights into the aetiology of BEEC in the last decade. Specifically, recent genetic studies have suggested that downstream regulator(s) of p63, Isl1, and other genes may play a role in the failure of the lower urinary tract to close.
- 1 June 2024
- Published by Medpharm Publications in African Urology
- Vol. 4 (se1) , S11-S15
Classic bladder exstrophy – the timing of initial closure and technical highlights
- 1 June 2024
- Published by Medpharm Publications in African Urology
- Vol. 4 (se1) , S11-S15
Classic bladder exstrophy – the timing of initial closure and technical highlights
- Open Access
- 10 January 2023
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 19 (3) , 277-283
Identifying variability in surgical practices and instrumentation for hypospadias repair across the Western Pediatric Urology Consortium (WPUC) network
- 10 January 2023
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 19 (3) , 277-283
Open AccessIdentifying variability in surgical practices and instrumentation for hypospadias repair across the Western Pediatric Urology Consortium (WPUC) network
- Open Access
- 6 December 2021
- Published by Elsevier in Urology Case Reports
- Vol. 41, 101971
46 XY undervirulized male DSD: Reporting a patient with prenatally diagnosed disorder/difference of sex development (DSD) with heterozygous LHCGR mutations
- 6 December 2021
- Published by Elsevier in Urology Case Reports
- Vol. 41, 101971
Open Access46 XY undervirulized male DSD: Reporting a patient with prenatally diagnosed disorder/difference of sex development (DSD) with heterozygous LHCGR mutations